NCT03287492 2026-01-20
RCT of QPS vs General Information Sheet
M.D. Anderson Cancer Center
Phase NA Active not recruiting
Clinical Trials
14 trialsNCT05997342 2025-08-11
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT06344351 2025-05-22
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT03122886 2024-12-17
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin
Mayo Clinic
Phase NA Completed
NCT06297642 2024-08-06
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Terminated
NCT02823652 2024-02-28
Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer
Eastern Cooperative Oncology Group
Phase NA Completed
NCT06165809 2023-12-29
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Withdrawn
NCT05985278 2023-08-14
Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
Peking University Cancer Hospital & Institute
Phase EARLY_PHASE1 Recruiting
NCT05867563 2023-07-10
Clinical Trial Evaluating the Safety of the TQB2103 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT05048160 2022-05-09
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT03051035 2021-09-20
First-in-Human Study of KO-947 in Non-Hematological Malignancies
Kura Oncology, Inc.
Phase 1 Terminated
NCT01867294 2020-01-09
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Academic and Community Cancer Research United
Phase 2 Completed
NCT02650583 2019-02-15
Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children
University of Washington
Phase NA Completed
NCT00244972 2017-04-27
Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed